PMV Pharmaceuticals, Inc.
PMVP
$1.56
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.42% | -60.70% | -65.45% | 6.49% | 14.87% |
| Total Depreciation and Amortization | -88.37% | -90.51% | -66.99% | -43.44% | -8.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.41% | 78.21% | 59.85% | 41.92% | 18.98% |
| Change in Net Operating Assets | 157.41% | 421.81% | 212.37% | -166.27% | -129.33% |
| Cash from Operations | -43.48% | -56.40% | -53.91% | 6.10% | 7.86% |
| Capital Expenditure | 95.57% | 91.21% | 91.42% | 95.36% | 31.91% |
| Sale of Property, Plant, and Equipment | -87.65% | 772.41% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.53% | 35.40% | 1,032.80% | 176.72% | 208.42% |
| Cash from Investing | 31.53% | 38.24% | 934.36% | 175.52% | 205.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.34% | -33.57% | -99.15% | -99.09% | -99.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.34% | -33.57% | -99.15% | -99.09% | -99.12% |
| Foreign Exchange rate Adjustments | 120.00% | -130.00% | -116.67% | -- | -202.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.21% | -309.45% | 73.47% | 103.01% | 103.33% |